Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

Joshua D. Lovelock, Michelle M. Monasky, Euy Myoung Jeong, Harvey A. Lardin, Hong Liu, Bindiya G. Patel, Domenico M. Taglieri, Lianzhi Gu, Praveen Kumar, Narayan Pokhrel, Dewan Zeng, Luiz Belardinelli, Dan Sorescu, R. John Solaro, Samuel C. Dudley

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Rationale: Previously, we demonstrated that a deoxycorticosterone acetate (DOCA)-salt hypertensive mouse model produces cardiac oxidative stress and diastolic dysfunction with preserved systolic function. Oxidative stress has been shown to increase late inward sodium current (I Na), reducing the net cytosolic Ca 2+ efflux. Objective: Oxidative stress in the DOCA-salt model may increase late I Na, resulting in diastolic dysfunction amenable to treatment with ranolazine. Methods and Results: Echocardiography detected evidence of diastolic dysfunction in hypertensive mice that improved after treatment with ranolazine (E/E′:sham, 31.9±2.8, sham+ranolazine, 30.2±1.9, DOCA-salt, 41.8±2.6, and DOCA-salt+ranolazine, 31.9±2.6; P=0.018). The end-diastolic pressure-volume relationship slope was elevated in DOCA-salt mice, improving to sham levels with treatment (sham, 0.16±0.01 versus sham+ranolazine, 0.18±0.01 versus DOCA-salt, 0.23±0.2 versus DOCA-salt+ranolazine, 0.17±0.0 1 mm Hg/L; PNa nor the Ca 2+ transients were different from sham myocytes. Detergent extracted fiber bundles from DOCA-salt hearts demonstrated increased myofilament response to Ca 2+ with glutathionylation of myosin binding protein C. Treatment with ranolazine ameliorated the Ca 2+ response and cross-bridge kinetics. Conclusions: Diastolic dysfunction could be reversed by ranolazine, probably resulting from a direct effect on myofilaments, indicating that cardiac oxidative stress may mediate diastolic dysfunction through altering the contractile apparatus.

Original languageEnglish
Pages (from-to)841-850
Number of pages10
JournalCirculation Research
Volume110
Issue number6
DOIs
Publication statusPublished - Mar 16 2012

Fingerprint

Desoxycorticosterone
Myofibrils
Acetates
Salts
Calcium
Oxidative Stress
Ranolazine
Detergents
Muscle Cells
Echocardiography
Therapeutics
Sodium
Placebos
Blood Pressure

Keywords

  • diastole
  • myofilaments
  • oxidative stress
  • ranolazine

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity. / Lovelock, Joshua D.; Monasky, Michelle M.; Jeong, Euy Myoung; Lardin, Harvey A.; Liu, Hong; Patel, Bindiya G.; Taglieri, Domenico M.; Gu, Lianzhi; Kumar, Praveen; Pokhrel, Narayan; Zeng, Dewan; Belardinelli, Luiz; Sorescu, Dan; Solaro, R. John; Dudley, Samuel C.

In: Circulation Research, Vol. 110, No. 6, 16.03.2012, p. 841-850.

Research output: Contribution to journalArticle

Lovelock, JD, Monasky, MM, Jeong, EM, Lardin, HA, Liu, H, Patel, BG, Taglieri, DM, Gu, L, Kumar, P, Pokhrel, N, Zeng, D, Belardinelli, L, Sorescu, D, Solaro, RJ & Dudley, SC 2012, 'Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity', Circulation Research, vol. 110, no. 6, pp. 841-850. https://doi.org/10.1161/CIRCRESAHA.111.258251
Lovelock, Joshua D. ; Monasky, Michelle M. ; Jeong, Euy Myoung ; Lardin, Harvey A. ; Liu, Hong ; Patel, Bindiya G. ; Taglieri, Domenico M. ; Gu, Lianzhi ; Kumar, Praveen ; Pokhrel, Narayan ; Zeng, Dewan ; Belardinelli, Luiz ; Sorescu, Dan ; Solaro, R. John ; Dudley, Samuel C. / Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity. In: Circulation Research. 2012 ; Vol. 110, No. 6. pp. 841-850.
@article{ad54b256331e40f1b1a88385bb5846c0,
title = "Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity",
abstract = "Rationale: Previously, we demonstrated that a deoxycorticosterone acetate (DOCA)-salt hypertensive mouse model produces cardiac oxidative stress and diastolic dysfunction with preserved systolic function. Oxidative stress has been shown to increase late inward sodium current (I Na), reducing the net cytosolic Ca 2+ efflux. Objective: Oxidative stress in the DOCA-salt model may increase late I Na, resulting in diastolic dysfunction amenable to treatment with ranolazine. Methods and Results: Echocardiography detected evidence of diastolic dysfunction in hypertensive mice that improved after treatment with ranolazine (E/E′:sham, 31.9±2.8, sham+ranolazine, 30.2±1.9, DOCA-salt, 41.8±2.6, and DOCA-salt+ranolazine, 31.9±2.6; P=0.018). The end-diastolic pressure-volume relationship slope was elevated in DOCA-salt mice, improving to sham levels with treatment (sham, 0.16±0.01 versus sham+ranolazine, 0.18±0.01 versus DOCA-salt, 0.23±0.2 versus DOCA-salt+ranolazine, 0.17±0.0 1 mm Hg/L; PNa nor the Ca 2+ transients were different from sham myocytes. Detergent extracted fiber bundles from DOCA-salt hearts demonstrated increased myofilament response to Ca 2+ with glutathionylation of myosin binding protein C. Treatment with ranolazine ameliorated the Ca 2+ response and cross-bridge kinetics. Conclusions: Diastolic dysfunction could be reversed by ranolazine, probably resulting from a direct effect on myofilaments, indicating that cardiac oxidative stress may mediate diastolic dysfunction through altering the contractile apparatus.",
keywords = "diastole, myofilaments, oxidative stress, ranolazine",
author = "Lovelock, {Joshua D.} and Monasky, {Michelle M.} and Jeong, {Euy Myoung} and Lardin, {Harvey A.} and Hong Liu and Patel, {Bindiya G.} and Taglieri, {Domenico M.} and Lianzhi Gu and Praveen Kumar and Narayan Pokhrel and Dewan Zeng and Luiz Belardinelli and Dan Sorescu and Solaro, {R. John} and Dudley, {Samuel C.}",
year = "2012",
month = "3",
day = "16",
doi = "10.1161/CIRCRESAHA.111.258251",
language = "English",
volume = "110",
pages = "841--850",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

AU - Lovelock, Joshua D.

AU - Monasky, Michelle M.

AU - Jeong, Euy Myoung

AU - Lardin, Harvey A.

AU - Liu, Hong

AU - Patel, Bindiya G.

AU - Taglieri, Domenico M.

AU - Gu, Lianzhi

AU - Kumar, Praveen

AU - Pokhrel, Narayan

AU - Zeng, Dewan

AU - Belardinelli, Luiz

AU - Sorescu, Dan

AU - Solaro, R. John

AU - Dudley, Samuel C.

PY - 2012/3/16

Y1 - 2012/3/16

N2 - Rationale: Previously, we demonstrated that a deoxycorticosterone acetate (DOCA)-salt hypertensive mouse model produces cardiac oxidative stress and diastolic dysfunction with preserved systolic function. Oxidative stress has been shown to increase late inward sodium current (I Na), reducing the net cytosolic Ca 2+ efflux. Objective: Oxidative stress in the DOCA-salt model may increase late I Na, resulting in diastolic dysfunction amenable to treatment with ranolazine. Methods and Results: Echocardiography detected evidence of diastolic dysfunction in hypertensive mice that improved after treatment with ranolazine (E/E′:sham, 31.9±2.8, sham+ranolazine, 30.2±1.9, DOCA-salt, 41.8±2.6, and DOCA-salt+ranolazine, 31.9±2.6; P=0.018). The end-diastolic pressure-volume relationship slope was elevated in DOCA-salt mice, improving to sham levels with treatment (sham, 0.16±0.01 versus sham+ranolazine, 0.18±0.01 versus DOCA-salt, 0.23±0.2 versus DOCA-salt+ranolazine, 0.17±0.0 1 mm Hg/L; PNa nor the Ca 2+ transients were different from sham myocytes. Detergent extracted fiber bundles from DOCA-salt hearts demonstrated increased myofilament response to Ca 2+ with glutathionylation of myosin binding protein C. Treatment with ranolazine ameliorated the Ca 2+ response and cross-bridge kinetics. Conclusions: Diastolic dysfunction could be reversed by ranolazine, probably resulting from a direct effect on myofilaments, indicating that cardiac oxidative stress may mediate diastolic dysfunction through altering the contractile apparatus.

AB - Rationale: Previously, we demonstrated that a deoxycorticosterone acetate (DOCA)-salt hypertensive mouse model produces cardiac oxidative stress and diastolic dysfunction with preserved systolic function. Oxidative stress has been shown to increase late inward sodium current (I Na), reducing the net cytosolic Ca 2+ efflux. Objective: Oxidative stress in the DOCA-salt model may increase late I Na, resulting in diastolic dysfunction amenable to treatment with ranolazine. Methods and Results: Echocardiography detected evidence of diastolic dysfunction in hypertensive mice that improved after treatment with ranolazine (E/E′:sham, 31.9±2.8, sham+ranolazine, 30.2±1.9, DOCA-salt, 41.8±2.6, and DOCA-salt+ranolazine, 31.9±2.6; P=0.018). The end-diastolic pressure-volume relationship slope was elevated in DOCA-salt mice, improving to sham levels with treatment (sham, 0.16±0.01 versus sham+ranolazine, 0.18±0.01 versus DOCA-salt, 0.23±0.2 versus DOCA-salt+ranolazine, 0.17±0.0 1 mm Hg/L; PNa nor the Ca 2+ transients were different from sham myocytes. Detergent extracted fiber bundles from DOCA-salt hearts demonstrated increased myofilament response to Ca 2+ with glutathionylation of myosin binding protein C. Treatment with ranolazine ameliorated the Ca 2+ response and cross-bridge kinetics. Conclusions: Diastolic dysfunction could be reversed by ranolazine, probably resulting from a direct effect on myofilaments, indicating that cardiac oxidative stress may mediate diastolic dysfunction through altering the contractile apparatus.

KW - diastole

KW - myofilaments

KW - oxidative stress

KW - ranolazine

UR - http://www.scopus.com/inward/record.url?scp=84862776882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862776882&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.111.258251

DO - 10.1161/CIRCRESAHA.111.258251

M3 - Article

C2 - 22343711

AN - SCOPUS:84862776882

VL - 110

SP - 841

EP - 850

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -